Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
X Financial A ADR | XYF | Nov 20, 2024 | 6.25 | 0.00 |
X3 Holdings | XTKG | Nov 20, 2024 | 0.09 | -37.89 |
X4 Pharmaceuticals | XFOR | Nov 20, 2024 | 0.34 | -7.50 |
XAI Octagon Floating Rate & Alternative Income Term Trust | XFLT | Nov 20, 2024 | 6.89 | -0.14 |
XAI Octagon Floating Rate & Alternative Income Term Trust 20 | XFLT-A | Nov 20, 2024 | 25.15 | +0.32 |
XBiotech | XBIT | Nov 20, 2024 | 6.49 | -2.70 |
XBP Europe | XBP | Nov 20, 2024 | 1.31 | +5.65 |
Xcel Brands | XELB | Nov 20, 2024 | 0.71 | +0.01 |
Xcel Energy | XEL | Nov 20, 2024 | 70.05 | +0.69 |
XChange Tec.Inc ADR | XHG | Nov 20, 2024 | 1.45 | +6.62 |
XCHG Limited - ADS | XCH | Nov 20, 2024 | 16.00 | 0.00 |
Xencor | XNCR | Nov 20, 2024 | 23.72 | +0.38 |
Xenetic Biosciences | XBIO | Nov 20, 2024 | 3.99 | +2.31 |
Xenia Hotels & Resorts | XHR | Nov 20, 2024 | 14.76 | -0.40 |
Xenon Pharmaceuticals | XENE | Nov 20, 2024 | 39.34 | +1.26 |
Xeris Biopharma | XERS | Nov 20, 2024 | 3.06 | +1.66 |
Xerox | XRX | Nov 20, 2024 | 8.39 | -0.36 |
XIAO-I ADR | AIXI | Nov 20, 2024 | 5.46 | +2.63 |
Xilio Therapeutics | XLO | Nov 20, 2024 | 0.94 | -7.73 |
Xinyuan Real Estate ADR | XIN | Nov 20, 2024 | 3.51 | -1.13 |
XOMA | XOMA | Nov 20, 2024 | 30.02 | -0.27 |
XOMA A Pref | XOMAP | Nov 20, 2024 | 25.69 | -0.70 |
XOMA B Pref | XOMAO | Nov 20, 2024 | 25.34 | -0.04 |
Xometry A | XMTR | Nov 20, 2024 | 29.65 | -0.50 |
XORTX Therapeutics | XRTX | Nov 20, 2024 | 1.26 | -3.17 |
Xos | XOS | Nov 20, 2024 | 3.86 | +1.65 |
XP A | XP | Nov 20, 2024 | 15.67 | -6.06 |
XPEL | XPEL | Nov 20, 2024 | 43.25 | +1.72 |
XPeng A ADR | XPEV | Nov 20, 2024 | 12.64 | +0.96 |
Xperi | XPER | Nov 20, 2024 | 8.65 | +2.37 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.